SEC Form 4 · accession 0000899243-19-003138
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Molineaux
Officer — PRESIDENT AND CEO · Director
Period of report
Feb 7, 2019
Accepted (ET)
Feb 11, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 7, 2019 | G | 12,986 | $0.00 | D | 395,588 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares transferred to the Reporting Person's children. The securities owned by the children are not beneficially owned by the Reporting Person.
- F2Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee